1. A Covid-19 Vaccine Could Be Ready Late This Year, Bernstein Analyst Says  Barron's
  2. Listen: Moderna's scant coronavirus data & the world's reliance on biotech  STAT
  3. A Vaccine With a Poison Pill  Bloomberg
  4. Race to Successful COVID Vaccine May Shape India’s Global Position  The Quint
  5. View Full Coverage on Google News
Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.

A Covid-19 Vaccine Could Be Ready Late This Year, Bernstein Analyst Says - Barron's

404 Not Found

Bloomberg - Are you a robot?

Will vaccine for COVID-19 play into the developing narrative of seeing a shift of technological and scientific innovation from the Global North to the Global South? Or will the race simply re-instate the Cold War notion of Western world dominance?Will COVID vaccine shift narrative in technological & scientific innovation from Global North to Global South? 

Will India Overtake China As Global Power If It Wins the Vaccine Race? | OPINION

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“Moderna announced promising vaccine results.....and the executives then sell 30 million in stocks. Something smells funny! #COVIDー19”

Joseph Sakran on Twitter: "Moderna announced promising vaccine results.....and the executives then sell 30 million in stocks. Something smells funny! #COVIDー19… https://t.co/3P1m564hkW"

“Well I’m excited. Dr Fauci is joining us at 12pmET TODAY on @CNBC @HalftimeReport. We’ll talk Moderna data, other vaccines for #COVID19, remdesivir and his outlook right now on the course of the pandemic. Tune in.”

Meg Tirrell on Twitter: "Well I’m excited. Dr Fauci is joining us at 12pmET TODAY on @CNBC @HalftimeReport. We’ll talk Moderna data, other vaccines for #COVID19, remdesivir and his outlook right now on the course of the pandemic. Tune in."

“$MRNA Moderna shares are trading higher after Anthony Fauci reportedly said he's "cautiously optimistic" about a Moderna coronavirus vaccine. https://t.co/JcazQtWPuO”

Ophir Gottlieb on Twitter: "$MRNA Moderna shares are trading higher after Anthony Fauci reportedly said he's "cautiously optimistic" about a Moderna coronavirus vaccine. https://t.co/JcazQtWPuO"

Skeptics are questioning the biotech's recent coronavirus vaccine-related announcements.Skeptics are questioning the biotech's recent coronavirus vaccine-related announcements.

Why Moderna Stock Dropped Thursday | The Motley Fool

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill

Welcome to Dispensed. Inside, how the pandemic has transformed the drug industry and how hospitals handle future surges of patients.Welcome to Dispensed. Inside, how the pandemic has transformed the drug industry and how hospitals handle future surges of patients.

Dispensed Business Insider's weekly healthcare newsletter May 22 - Business Insider

A new poll from Reuters and Ipsos has found that a quarter of Americans weren't interested in taking a Covid-19 vaccine, which doesn't even exist.Covid-19 has wreaked havoc on the world, causing 5 million recorded infections and 333,000 deaths so far, with a third of the world under lockdown. In orde

A Quarter Of Americans Are Hesitant About Taking A Covid-19 Vaccine That Doesn't Yet Exist | IFLScience

Dr. Anthony Fauci said he's optimistic about one of the CCP virus vaccine candidates quickly moving through clinical ...Dr. Anthony Fauci said he's optimistic about one of the CCP virus vaccine candidates quickly moving through clinical ...

Fauci ‘Cautiously Optimistic’ About Leading CCP Virus Vaccine Candidate

Access Denied

Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on…Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on…

The first coronavirus vaccine trial was "promising," but what does that really mean?

The firm says its experimental mRNA vaccine is safe and induced promising levels of antibodies in a small Phase I clinical trial

Moderna provides cursory glance at first COVID-19 vaccine data

Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.

Moderna CEO and other execs made millions on vaccine announcement - CBS News

About 2.4 million Americans filed for unemployment last week. And we're in for an extremely active hurricane season. It's Thursday's news.About 2.4 million Americans filed for unemployment last week. And we're in for an extremely active hurricane season. It's Thursday's news.

Coronavirus, vaccine, Michigan flooding, Ford, unemployment: Thursday's news

Welcome to Friday's Overnight Health Care.Welcome to Friday's Overnight Health Care.

Overnight Health Care: Fauci on why a vaccine by end of year is 'aspirational' | Trump demands governors allow churches to open | Birx says DC metro area has highest positivity rate | TheHill

Welcome to Friday's Overnight Health Care.Welcome to Friday's Overnight Health Care.

Overnight Health Care: Fauci on why a vaccine by end of year is 'aspirational' | Trump demands governors allow churches to open | Birx says DC metro area has highest positivity rate | TheHill

It feels like our only hope against coronavirus, so...when will a COVID-19 vaccine be ready? Experts explain the development timeline from start to finish.Be prepared for a long wait.

When will a COVID-19 vaccine be ready? Be ready to wait | Well+Good

As Moderna reported encouraging news on a vaccine trial, top executives moved their stock.As Moderna reported encouraging news on a vaccine trial, top executives moved their stock.

Modern execs sell stock amid coronavirus vaccine news - New York Daily News

On Tuesday 12 May, Moderna Therapeutics received Fast Track designation from the Food and Drug Administration (FDA) for its Covid-19 candidate vaccine.On Tuesday 12 May, Moderna Therapeutics received Fast Track designation from the Food and Drug Administration (FDA) for its Covid-19 candidate vaccine.

Moderna Covid-19 vaccine looks to gain first approval

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters. The project will compress what isThe United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters. The project will compress what is

Exclusive: U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline

Dr. Anthony Fauci says it's "conceivable" a coronavirus vaccine could be ready within months but cautions "when you're dealing with vaccines, there could be so many things that get in the way."Dr. Anthony Fauci says it's "conceivable" a coronavirus vaccine could be ready within months but cautions "when you're dealing with vaccines, there could be so many things that get in the way."

Fauci Optimistic About Moderna Vaccine Trial : Shots - Health News : NPR

Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.

The Coronavirus Vaccine Is on Track to Be the Fastest Ever Developed | The New Yorker

A coronavirus vaccine might be the door out of this hell. What if our neighbors refuse to walk through it?As the COVID-19 pandemic has unwound around the world and in North Texas, there's been a pot of gold at the end of the rainbow. The only surefire way out of our new confines, according to epidemiologists and public health officials, is researchers finding a vaccine for the novel coronavirus...

What If Texans Won't Get a Coronavirus Vaccine? | Dallas Observer

The vaccine appeared "generally safe and well-tolerated" on volunteers.The vaccine appeared "generally safe and well-tolerated" on volunteers.

Fauci on Moderna vaccine: "I'm cautiously optimistic" - Axios

NoCookies | The Australian

Read the latest Granada stories, Liverpool School of Tropical Medicine taking part Covid-19 vaccine trials on ITV News, videos, stories and all the latest Granada newsLiverpool School of Tropical Medicine has begun recruiting frontline health and social care workers to take part in a COVID-19 vaccine trial. The school has been selected as one of the UK sites for phase III of the University of Oxford’s COVID-19 vaccine clinical trial. Led by Professor Andrew Pollard from the Oxford Vaccine Group, the trial will study the efficacy and safety of the candidate COVID-19 vaccine in healthy adults. The team at LSTM, under the leadership of Professor Daniela Ferreira: “We were delighted to be asked by Professor Pollard to be a site for the study. From the vaccine candidates we have in therace against COVID, the Oxford vaccine is progressing at an amazing pace. If the trials demonstrate this vaccine is safe and effective there will be millions of doses already produced that could be quickly administered. The potential impact of this could be massive on two fronts, by saving millions of lives not only in the UK, but also globally, as well as the economic benefits of allowing society to get back to normal without the risk of future COVID-19 peaks.”

Liverpool School of Tropical Medicine taking part Covid-19 vaccine trials | Granada - ITV News

Dr. Anthony Fauci said that he's "cautiously optimistic" about the coronavirus vaccine Moderna is working on. The National Institute of Allergy and Infectious Diseases (NIAID) is one of Moderna's partners on the COVID-19 drug, but the agency has been quiet this week on the heels of Moderna's ...Dr. Anthony Fauci said that he’s “cautiously optimistic” about the coronavirus vaccine Moderna is working on. The National Institute of Allergy and Infectious Diseases (NIAID) is …

Dr. Fauci has some good news about a coronavirus vaccine – BGR

Dr. Fauci expressed confidence in a new vaccine being developed by a Massachusetts firm

Coronavirus vaccine for United States possible by December, Dr. Anthony Fauci says; ‘I think it is conceivable’ - masslive.com

Covid-19 arrived in Singapore on Jan 23.. Read more at straitstimes.com.Health News -Covid-19 arrived in Singapore on Jan 23.. Read more at straitstimes.com.

Singapore's search for a cure and vaccine for Covid-19, Health News & Top Stories - The Straits Times

Even with the accelerated efforts, a potential vaccine must go through a series of trials to tests its safety and efficacy and it may take more than 12-18 months for the same.Even with the accelerated efforts, a potential vaccine must go through a series of trials to tests its safety and efficacy and it may take more than 12-18 months for the same.

Coronavirus vaccine current update / COVID-19 vaccines drugs latest news: Oxford vaccine failure to Moderna’s favourable results, here is the latest status of COVID-19 vaccines and drugs

Even with the accelerated efforts, a potential vaccine must go through a series of trials to tests its safety and efficacy and it may take more than 12-18 months for the same.Even with the accelerated efforts, a potential vaccine must go through a series of trials to tests its safety and efficacy and it may take more than 12-18 months for the same.

Coronavirus vaccine current update / COVID-19 vaccines drugs latest news: Oxford vaccine failure to Moderna’s favourable results, here is the latest status of COVID-19 vaccines and drugs

An early trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and effective at prompting an immune response.An early trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and effective at prompting an immune response.

Early results promising for potential COVID-19 vaccine to be tested on Canadians | CP24.com

In interviews on CNN and NPR, he said the results from an early-stage trial by the Cambridge biotech are « promising. »In interviews on CNN and NPR, he said the results from an early-stage trial by the Cambridge biotech are « promising. »

Fauci ‘cautiously optimistic’ about Moderna’s experimental coronavirus vaccine - The Boston Globe

by Sanjay Mishra, Vanderbilt University Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on Wall St

What the phase 1 trials of the first COVID-19 vaccine really mean – Alternet.org

The sales occurred after Moderna (MRNA) excited Wall Street before markets opened Monday by announcing encouraging vaccine trial results. Moderna's market value swelled to $29 billion -- even though the company has no marketed products.The sales occurred after Moderna (MRNA) excited Wall Street before markets opened Monday by announcing encouraging vaccine trial results. Moderna's market value swelled to $29 billion -- even though the company has no marketed products.

Moderna Unveiled Promising Coronavirus Vaccine Results. Then Top Execs Dumped Nearly $30mn of Stock

US plans massive coronavirus vaccine testing effort to meet year-end deadlineThe United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the programme told Reuters.

US plans massive coronavirus vaccine testing effort to meet year-end deadline - bdnews24.com

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the programme told Reuters.

US plans massive coronavirus vaccine testing effort to meet year-end deadline

Dr. Anthony Fauci says it's "conceivable" a coronavirus vaccine could be ready within months but cautions "when you're dealing with vaccines, there could be so many things that get in the way."Dr. Anthony Fauci says it's "conceivable" a coronavirus vaccine could be ready within months but cautions "when you're dealing with vaccines, there could be so many things that get in the way."

Fauci Voices Cautious Optimism About Moderna Vaccine, Calling Trial 'Quite Promising' | WBUR News

Moderna’s press release on its COVID-19 mRNA vaccine trials — called mRNA-1273 — heightened hopes but missed key details.Moderna’s press release on its COVID-19 mRNA vaccine trials — called mRNA-1273 — heightened hopes but missed key details.

What Moderna didn’t reveal about the first Covid vaccine’s phase 1 trial

Moderna’s press release on its COVID-19 mRNA vaccine trials — called mRNA-1273 — heightened hopes but missed key details.Moderna’s press release on its COVID-19 mRNA vaccine trials — called mRNA-1273 — heightened hopes but missed key details.

What Moderna didn’t reveal about the first Covid vaccine’s phase 1 trial

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is “cautiously optimistic” about Moderna Inc's ...Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is “cautiously optimistic” about Moderna Inc's (NASDAQ: MRNA) ...

(MRNA) - Fauci Calls Moderna's Coronavirus Vaccine Candidate 'Quite Promising' | Benzinga

"Having looked at the data myself, it is really quite promising," Dr. Anthony Fauci said about Moderna's COVID-19 vaccine candidate.

Moderna climbs 5% as Fauci calls its early COVID-19 vaccine data 'quite promising'